Literature DB >> 6307199

Cyclic AMP levels in relation to membrane phospholipid variations in Neurospora crassa.

C Gabrielides, J Zrike, W A Scott.   

Abstract

The correlation between membrane phospholipid composition and total cyclic AMP levels was investigated by using Neurospora lipid auxotrophs under various supplementation conditions. The lipid composition of the supplemented cultures was determined, and the intracellular and extracellular cyclic AMP levels were measured at various stages of the culture growth. Kinetic parameters and the thermostability of adenylate cyclase and of cyclic AMP-dependent phosphodiesterase were measured under all supplementation conditions. In inositol deficient inl cultures the levels of intracellular cyclic AMP decreased exponentially towards the end of the log phase and thereafter. In chol-l; chol-2 cultures, grown in N-monomethylethanolamine and low choline supplementation, the level of intracellular cyclic AMP decreased as function of decreasing exogenous choline supplement. Rates of cyclic AMP extrusion in all cultures were comparable on dry weight basis, and thus not affected by the mycelial lipid composition. Adenylate cyclase activity and thermostability decreased under those supplementation conditions resulting in reduction of cyclic AMP. Cyclic AMP-dependent phosphodiesterase was insensitive to phospholipid changes. Accordingly, it is suggested that specific perturbations in cellular phospholipid composition affect the membrane-bound adenylate cyclase and hence the cyclic AMP synthesis in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307199     DOI: 10.1007/bf00407941

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  20 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Adenosine 3',5'-cyclic monophosphate and morphology in Neurospora crassa: drug-induced alterations.

Authors:  W A Scott; B Solomon
Journal:  J Bacteriol       Date:  1975-05       Impact factor: 3.490

3.  Cyclic 3',5'-AMP phosphodiesterase of Neurospora crassa.

Authors:  W A Scott; B Solomon
Journal:  Biochem Biophys Res Commun       Date:  1973-08-06       Impact factor: 3.575

4.  The role of phosphatidylserine in the hormonal control of adenylate cyclase of rat liver plasma membranes.

Authors:  A Rethy; V Tomasi; A Trevisani; O Barnabei
Journal:  Biochim Biophys Acta       Date:  1972-12-01

5.  Restoration of glucagon responsiveness of solubilized myocardial adenyl cyclase by phosphatidylserine.

Authors:  G S Levey
Journal:  Biochem Biophys Res Commun       Date:  1971-04-02       Impact factor: 3.575

6.  The role of lipids in the activity of adenylate cyclase of rat liver plasma membranes.

Authors:  A Réthy; V Tomasi; A Trevisani
Journal:  Arch Biochem Biophys       Date:  1971-11       Impact factor: 4.013

7.  Separation of cyclic 3',5'-nucleoside monophosphates from other nucleotides on aluminum oxide columns. Application to the assay of adenyl cyclase and guanyl cyclase.

Authors:  A A White; T V Zenser
Journal:  Anal Biochem       Date:  1971-06       Impact factor: 3.365

8.  Detection of the ergosterol and episterol isomers lichesterol and fecosterol in nystatin-resistant mutants of Neurospora crassa.

Authors:  D C Morris; S Safe; R E Subden
Journal:  Biochem Genet       Date:  1974-12       Impact factor: 1.890

Review 9.  Newer developments in determination of bile acids and steroids by gas chromatography.

Authors:  A Kuksis
Journal:  Methods Biochem Anal       Date:  1966

10.  Adenosine 3':5'-cyclic monophosphate deficiency in Neurospora crassa.

Authors:  W A Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

View more
  1 in total

1.  Effects of inositol starvation on the levels of inositol phosphates and inositol lipids in Neurospora crassa.

Authors:  P L Lakin-Thomas
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.